` 7XB (Xbrane Biopharma AB) vs DAX Index Comparison - Alpha Spread

7XB
vs
D
DAX Index

Over the past 12 months, 7XB has significantly outperformed DAX Index, delivering a return of +89% compared to the DAX Index's +9% growth.

Stocks Performance
7XB vs DAX Index

Loading
7XB
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
7XB vs DAX Index

Performance Gap Between 7XB and GDAXI
HIDDEN
Show

Performance By Year
7XB vs DAX Index

Loading
7XB
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Xbrane Biopharma AB vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Xbrane Biopharma AB
Glance View

Market Cap
30.3m EUR
Industry
Biotechnology

Xbrane Biopharma AB is a biopharmaceutical company, which engages in the development and manufacture of biosimilars. The company is headquartered in Solna, Stockholm. The company went IPO on 2016-02-03. The company develops biogenerics for injectable slow release drugs and high-yield protein expression technology for the development of biosimilars. The firm's main products are Sperotide, a generic on the originator drug marketed under the trademarks Decapeptyl, Trelstar and Pamorelin, as well as Xlucane, a biosimilar on the originator drug sold under the trademark Lucentis.

7XB Intrinsic Value
Not Available
Back to Top